EDASALONEXENT

( DrugBank: Edasalonexent / KEGG DRUG: Edasalonexent )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
113	筋ジストロフィー	11

113. 筋ジストロフィー

臨床試験数 : 646 / 薬物数 : 471 - (DrugBank : 105) / 標的遺伝子数 : 59 - 標的パスウェイ数 : 170

trials per page:

Showing 1 to 10 of 11 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04322357 (ClinicalTrials.gov)	July 30, 2020	24/3/2020	Weekend Steroids and Exercise as Therapy for DMD	Impact and Interplay of Corticosteroid Regimen and Exercise Training on DMD Muscle Function	Duchenne Muscular Dystrophy (DMD)	Drug: Prednisone;Behavioral: In-home Exercise Training;Drug: Prednisone with daily edasalonexent;Dru ...	University of Florida	U.S. Army Medical Research and Development Command;Catabasis Pharmaceuticals	Recruiting	5 Years	8 Years	Male	89	Phase 2	United States
2	EUCTR2019-003563-22-IE (EUCTR)	23/06/2020	21/01/2020	A study to provide Edasalonexent to Pediatric Patients with Duchenne Muscular Dystrophy	An Open-Label Extension Study of Edasalonexentin Pediatric Patients with Duchenne Muscular Dystrophy ...	Duchenne Muscular Dystrophy MedDRA version: 20.0;Level: PT;Classification code 10013801;Term: Duchen ...	Product Name: Edasalonexent Product Code: CAT-1004 INN or Proposed INN: EDASALONEXENT	Catabasis Pharmaceuticals Inc.	NULL	Not Recruiting			Female: no Male: yes	140	Phase 3	United States;Canada;Ireland;Australia;Germany;United Kingdom;Sweden
3	EUCTR2019-003563-22-GB (EUCTR)	23/04/2020	13/01/2020	A study to provide Edasalonexent to Pediatric Patients with Duchenne Muscular Dystrophy	An Open-Label Extension Study of Edasalonexentin Pediatric Patients with Duchenne Muscular Dystrophy ...	Duchenne Muscular Dystrophy MedDRA version: 20.0;Level: PT;Classification code 10013801;Term: Duchen ...	Product Name: Edasalonexent Product Code: CAT-1004 INN or Proposed INN: EDASALONEXENT	Catabasis Pharmaceuticals Inc.	NULL	Not Recruiting			Female: no Male: yes	140	Phase 3	United States;Canada;Ireland;Australia;Germany;United Kingdom;Sweden
4	EUCTR2019-003563-22-DE (EUCTR)	16/04/2020	31/01/2020	A study to provide Edasalonexent to Pediatric Patients with Duchenne Muscular Dystrophy	An Open-Label Extension Study of Edasalonexentin Pediatric Patients with Duchenne Muscular Dystrophy ...	Duchenne Muscular Dystrophy MedDRA version: 20.0;Level: PT;Classification code 10013801;Term: Duchen ...	Product Name: Edasalonexent Product Code: CAT-1004 INN or Proposed INN: EDASALONEXENT	Catabasis Pharmaceuticals Inc.	NULL	Not Recruiting			Female: no Male: yes	140	Phase 3	United States;Canada;Ireland;Australia;Israel;Germany;United Kingdom;Sweden
5	EUCTR2019-003563-22-SE (EUCTR)	15/04/2020	03/02/2020	A study to provide Edasalonexent to Pediatric Patients with Duchenne Muscular Dystrophy	An Open-Label Extension Study of Edasalonexentin Pediatric Patients with Duchenne Muscular Dystrophy ...	Duchenne Muscular Dystrophy MedDRA version: 20.0;Level: PT;Classification code 10013801;Term: Duchen ...	Product Name: Edasalonexent Product Code: CAT-1004 INN or Proposed INN: EDASALONEXENT	Catabasis Pharmaceuticals Inc.	NULL	Not Recruiting			Female: no Male: yes	140	Phase 3	United States;Canada;Ireland;Australia;Germany;United Kingdom;Sweden
6	NCT03917719 (ClinicalTrials.gov)	March 14, 2019	12/4/2019	An Open-Label Extension Study of Edasalonexent in Boys With Duchenne Muscular Dystrophy	An Open-Label Extension Study of Edasalonexentin Pediatric Patients With Duchenne Muscular Dystrophy ...	Duchenne Muscular Dystrophy	Drug: Edasalonexent	Catabasis Pharmaceuticals	NULL	Terminated	4 Years	12 Years	Male	130	Phase 3	United States;Australia;Canada;Germany;Sweden;United Kingdom
7	EUCTR2018-000464-29-DE (EUCTR)	31/01/2019	24/09/2018	A study to compare edasalonexent with placebo in patients with Duchenne Muscular dystrophy	A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, GLOBAL PHASE 3 STUDY OF EDASALONEXENTIN PEDIATRIC PA ...	Duchenne muscular dystrophy MedDRA version: 20.0;Level: PT;Classification code 10013801;Term: Duchen ...	Product Name: Edasalonexent Product Code: CAT-1004 INN or Proposed INN: EDASALONEXENT Product Name: Eda ...	Catabasis Pharmaceuticals, Inc.	NULL	Not Recruiting			Female: no Male: yes	126	Phase 3	United States;Canada;Ireland;Australia;Israel;Germany;United Kingdom;Sweden
8	EUCTR2018-000464-29-IE (EUCTR)	16/01/2019	02/10/2018	A study to compare edasalonexentwith placebo in pediatric patients with Duchenne Muscular dystrophy. ...	A RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED, GLOBAL PHASE 3 STUDY OFEDASALONEXENT IN PEDIATRIC PA ...	Duchenne Muscular Dystrophy MedDRA version: 20.0;Level: PT;Classification code 10013801;Term: Duchen ...	Product Name: Edasalonexent Product Code: CAT-1004 INN or Proposed INN: Edasalonexent	Catabasis Pharmaceuticals, Inc.	NULL	Not Recruiting			Female: no Male: yes	126	Phase 3	United States;Canada;Ireland;Australia;Israel;Germany;United Kingdom;Sweden
9	EUCTR2018-000464-29-SE (EUCTR)	11/12/2018	24/09/2018	A study to compare edasalonexent with placebo in patients with Duchenne Muscular dystrophy.	A RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED, GLOBAL PHASE 3 STUDY OFEDASALONEXENT IN PEDIATRIC PA ...	Duchenne Muscular Dystrophy MedDRA version: 20.0;Level: PT;Classification code 10013801;Term: Duchen ...	Product Name: Edasalonexent Product Code: CAT-1004 INN or Proposed INN: Edasalonexent	Catabasis Pharmaceuticals, Inc.	NULL	Not Recruiting			Female: no Male: yes	126	Phase 3	Canada;Ireland;Australia;Israel;Germany;United Kingdom;Sweden;United States
10	NCT03703882 (ClinicalTrials.gov)	October 2, 2018	8/10/2018	Phase III Study of Edasalonexent in Boys With Duchenne Muscular Dystrophy	A Randomized, Double-Blind, Placebo-Controlled, Global Phase 3 Study of Edasalonexentin Pediatric Pa ...	Muscular Dystrophy, Duchenne	Drug: Edasalonexent;Drug: Placebo	Catabasis Pharmaceuticals	NULL	Completed	4 Years	7 Years	Male	131	Phase 3	United States;Australia;Canada;Germany;Ireland;Israel;Sweden;United Kingdom

First Previous1 2Next Last